03/23/2020
5:48 AM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2020
3:49 PM | Innovate Biopharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/20/2020
3:18 PM | Innovate Biopharmaceuticals (Subject)
| Form SC TO-I/A
| |
03/19/2020
4:16 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2020
3:22 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2020
3:16 PM | Innovate Biopharmaceuticals (Subject)
| Form SC TO-I/A
| |
02/28/2020
4:23 PM | Innovate Biopharmaceuticals (Subject)
| Form SC TO-I/A
| |
02/18/2020
5:59 AM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2020
3:15 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2020
3:30 PM | Innovate Biopharmaceuticals (Filer)
| Form DEFA14A
| |
01/22/2020
4:01 PM | Innovate Biopharmaceuticals (Filer)
| Form DEF 14A
| |
01/22/2020
3:32 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2020
3:32 PM | Innovate Biopharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/30/2019
3:15 PM | Innovate Biopharmaceuticals (Filer)
| Form PRE 14A
| |
12/20/2019
3:33 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2019
7:08 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2019
3:58 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2019
3:45 PM | Innovate Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/07/2019
5:59 AM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2019
5:41 PM | Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2019
5:39 PM | Innovate Biopharmaceuticals (Issuer)
Madan Jay P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2019
3:41 PM | Innovate Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2019
3:35 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2019
11:15 PM | Innovate Biopharmaceuticals (Filer)
| Form EFFECT
| |
07/03/2019
4:04 PM | Innovate Biopharmaceuticals (Issuer)
Sitar Edward J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
4:03 PM | Innovate Biopharmaceuticals (Filer)
| Form S-3/A
| |
07/03/2019
4:02 PM | Innovate Biopharmaceuticals (Issuer)
Sitar Edward J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/01/2019
4:00 PM | Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
4:03 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2019
7:03 PM | Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
4:03 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2019
8:13 PM | Innovate Biopharmaceuticals (Issuer)
JOHNSON LORIN K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2019
6:24 PM | Innovate Biopharmaceuticals (Issuer)
MAIDA ANTHONY E III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2019
4:31 PM | Innovate Biopharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2019
4:30 PM | Innovate Biopharmaceuticals (Issuer)
Proujansky Roy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2019
7:00 AM | Innovate Biopharmaceuticals (Issuer)
Madan Jay P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
4:01 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2019
3:04 PM | Innovate Biopharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
05/28/2019
3:30 PM | Innovate Biopharmaceuticals (Issuer)
Proujansky Roy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2019
7:44 AM | Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2019
3:52 PM | Innovate Biopharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/14/2019
1:11 PM | Innovate Biopharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
05/10/2019
3:32 PM | Innovate Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2019
8:11 AM | Innovate Biopharmaceuticals (Filer)
| Form 424B5
| |
04/29/2019
6:49 AM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2019
4:20 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2019
4:06 PM | Innovate Biopharmaceuticals (Filer)
| Form DEF 14A
| |
04/26/2019
6:00 AM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2019
3:51 PM | Innovate Biopharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/19/2019
6:53 AM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2019
4:28 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2019
4:14 PM | Innovate Biopharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/18/2019
8:08 AM | Innovate Biopharmaceuticals (Filer)
| Form 424B5
| |
03/15/2019
2:05 PM | Innovate Biopharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/13/2019
4:03 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2019
4:09 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2019
3:45 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2018
4:15 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2018
4:14 PM | Innovate Biopharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/14/2018
4:11 PM | Innovate Biopharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/10/2018
4:04 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2018
4:21 PM | Innovate Biopharmaceuticals (Issuer)
MAIDA ANTHONY E III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2018
4:21 PM | Innovate Biopharmaceuticals (Issuer)
JOHNSON LORIN K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2018
4:21 PM | Innovate Biopharmaceuticals (Issuer)
Proujansky Roy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2018
4:21 PM | Innovate Biopharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2018
6:18 PM | Innovate Biopharmaceuticals (Issuer)
Proujansky Roy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2018
6:16 PM | Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
4:08 PM | Innovate Biopharmaceuticals (Filer)
| Form CT ORDER
| |
11/29/2018
7:00 PM | Innovate Biopharmaceuticals (Issuer)
Prior Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2018
5:13 PM | Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/23/2018
4:13 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2018
4:27 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2018
4:15 PM | Innovate Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2018
4:24 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/26/2018
8:22 PM | Innovate Biopharmaceuticals (Filer)
| Form 424B5
| |
10/18/2018
1:14 PM | Innovate Biopharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/16/2018
3:25 PM | Innovate Biopharmaceuticals (Filer)
| Form DEF 14A
| |
10/05/2018
4:16 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2018
3:49 PM | Innovate Biopharmaceuticals (Filer)
| Form PRE 14A
| |
09/14/2018
5:58 PM | Innovate Biopharmaceuticals (Issuer)
Prior Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2018
5:00 PM | Innovate Biopharmaceuticals (Issuer)
Prior Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2018
4:49 PM | Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2018
7:41 PM | Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2018
7:39 PM | Innovate Biopharmaceuticals (Issuer)
Prior Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2018
7:38 PM | Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
| Form 4/A
| |
08/28/2018
5:19 PM | Innovate Biopharmaceuticals (Issuer)
Prior Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2018
5:17 PM | Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2018
3:33 PM | Almenoff June Sherie (Reporting)
Innovate Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2018
3:34 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2018
7:13 AM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2018
3:06 PM | Innovate Biopharmaceuticals (Filer)
| Form 424B3
| |
07/15/2018
11:15 PM | Innovate Biopharmaceuticals (Filer)
| Form EFFECT
| |
07/11/2018
4:03 PM | Innovate Biopharmaceuticals (Filer)
| Form S-3/A
| |
07/09/2018
4:02 PM | Innovate Biopharmaceuticals (Filer)
| Form S-3/A
| |
06/29/2018
4:21 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2018
4:00 PM | Innovate Biopharmaceuticals (Filer)
| Form 10-K/A
| |
06/20/2018
9:37 AM | Innovate Biopharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/18/2018
3:15 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2018
4:26 PM | Innovate Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2018
4:08 PM | Innovate Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
